Socati-ahead of the curve29 May 2019 10:38
Socati CEO to Address FDA Hearing, Call on Agency to Provide Regulatory Framework to Unleash CBD Industry Growth
• Socati CEO Josh Epstein picked from among hundreds of applicants to speak at first FDA hearing to regulate products containing, derived from hemp
• Selection comes as Socati ramps up production of high-quality broad-spectrum hemp extracts after acquiring large-scale processing facility---
Socati Corp., a leading manufacturer of broad-spectrum hemp extract, announced today that CEO Josh Epstein has been selected from among hundreds of applicants to speak at the Food and Drug Administration’s (FDA) first public hearing on hemp-derived compounds. The FDA is seeking industry responses as it evaluates regulatory pathways for products containing and derived from hemp, including CBD.
Epstein will call on regulators to act quickly to deliver guidance on claims, quality and labelling, ensuring that consumers can safely derive the greatest value from this ingredient and the U.S. economy can realize the full economic potential of this fast-growing industry.